Responses
Other content recommended for you
- Healthcare professionals’ responsibility for informing relatives at risk of hereditary disease
- Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry
- Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
- Cultural aspects of cancer genetics: setting a research agenda
- Genetic counselling in ALS: facts, uncertainties and clinical suggestions
- Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer
- Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals
- Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations